Background: Visuoperceptual deficits in dementia are common and can reduce quality of life. Testing of visuoperceptual function is often confounded by impairments in other cognitive domains and motor dysfunction. We aimed to develop, pilot, and test a novel visuocognitive prototype test battery which addressed these issues, suitable for both clinical and functional imaging use. Methods: We recruited 23 participants (14 with dementia, 6 of whom had extrapyramidal motor features, and 9 age-matched controls). The novel Newcastle visual perception prototype battery (NEVIP-B-Prototype) included angle, color, face, motion and form perception tasks, and an adapted response system. It allows for individualized task difficulties. Participants were t...
Alzheimer's disease (AD) is the most frequent cause of dementia. The clinical symptoms of AD begin w...
Alzheimer's disease (AD) is known to cause a variety of disturbances of higher visual functions that...
Objective: Amnesic mild cognitive impairment (MCIa) is often characterized as an early stage of Alzh...
Background: Visuoperceptual deficits in dementia are common and can reduce quality of life. Testing ...
OBJECTIVE Visuoperceptual deficits are common in dementia with Lewy bodies (DLB) and Alzheimer di...
Early detection of Alzheimer’s disease (AD) and other dementias is of great public health impor...
BACKGROUND AND PURPOSE: Alzheimer’s disease is associated with progressive visuo-spatial dysfunction...
OBJECTIVES: Approximately 30% of Alzheimer’s disease (AD) patients are misdiagnosed due to overlappi...
Spatial abilities decline in normal aging and decrease faster and earlier in Alzheimer's disease (AD...
Research has demonstrated that testing of long-term visual memory is extraordinarily sensitive to de...
Aim: The Frontal Assessment Battery (FAB) has been used in different clinical settings as a valuable...
Alzheimer’s disease (AD) is the most frequent cause of dementia. The clinical symptoms of AD begin w...
The overall goal of this project is to develop a functional magnetic resonance imaging (fMRI) applic...
OBJECTIVE: The authors examined the interaction of Alzheimer's disease severity and visual stimulus ...
As the age of an individual progresses, they are prone to more diseases; dementia is one of these ag...
Alzheimer's disease (AD) is the most frequent cause of dementia. The clinical symptoms of AD begin w...
Alzheimer's disease (AD) is known to cause a variety of disturbances of higher visual functions that...
Objective: Amnesic mild cognitive impairment (MCIa) is often characterized as an early stage of Alzh...
Background: Visuoperceptual deficits in dementia are common and can reduce quality of life. Testing ...
OBJECTIVE Visuoperceptual deficits are common in dementia with Lewy bodies (DLB) and Alzheimer di...
Early detection of Alzheimer’s disease (AD) and other dementias is of great public health impor...
BACKGROUND AND PURPOSE: Alzheimer’s disease is associated with progressive visuo-spatial dysfunction...
OBJECTIVES: Approximately 30% of Alzheimer’s disease (AD) patients are misdiagnosed due to overlappi...
Spatial abilities decline in normal aging and decrease faster and earlier in Alzheimer's disease (AD...
Research has demonstrated that testing of long-term visual memory is extraordinarily sensitive to de...
Aim: The Frontal Assessment Battery (FAB) has been used in different clinical settings as a valuable...
Alzheimer’s disease (AD) is the most frequent cause of dementia. The clinical symptoms of AD begin w...
The overall goal of this project is to develop a functional magnetic resonance imaging (fMRI) applic...
OBJECTIVE: The authors examined the interaction of Alzheimer's disease severity and visual stimulus ...
As the age of an individual progresses, they are prone to more diseases; dementia is one of these ag...
Alzheimer's disease (AD) is the most frequent cause of dementia. The clinical symptoms of AD begin w...
Alzheimer's disease (AD) is known to cause a variety of disturbances of higher visual functions that...
Objective: Amnesic mild cognitive impairment (MCIa) is often characterized as an early stage of Alzh...